/Investor DB

Abingworth — 2013 Investments

2 investments dated 2013 · listed companies and verified rows first · show all

Avedro, Inc.avedro.comin𝕏Mar 2013 · $43Macquired by Glaukos

Avedro is an ophthalmic company focused on corneal health, known for bio-activated cross-linking therapies such as the KXL system and riboflavin-based treatments used to address progressive keratoconus.

BiotechHealthtechMedical DevicesWaltham, US

David F. Muller(Executive Officer, Director)inBrian J. Roberts(Executive Officer)inRhonda J. Bracey(Executive Officer)inThomas W. Burns(Chairman & Chief Executive Officer)

BoardJason Hong(Director)Jeff Dykan(Director)in

Co-investorsAPERTURE Venture PartnersLAVLilly Asia VenturesSCP Vitalife PartnersThird Point VenturesWestern Technology Investment+5 more

Pixium Visionpixium-vision.comSeries A · Nov 2013 · $20M

Pixium Vision SA developed the PRIMA System, an implantable device for treating late-stage macular degeneration, and ran clinical trials in Europe.

BiotechHealthtechMedical Devices

Co-investorsAgoranovSofinnova PartnersBpifranceOmnes Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.